Telehealth Successes and Challenges

Making Mesothelioma Patient Research Happen: The United Kingdom Experience

U.S. Drug Approvals: 2010 - 2020

Milestones in Lung Cancer Treatment

Time to End the Debate on Genomic Testing in NSCLC

Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade

Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin Filipits

Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis, and Prognostication

Grappling with Coronavirus (SARS-CoV-2)

Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

Treating Patients with MET Alterations: A Q&A with Dr. Ravi Salgia

TRK Inhibition in TRK Fusion–Positive Lung Cancers